Clinical trial
Salivary Inflammatory Markers (Interleukin -1β, Interleukin -6, C- Reactive Protein) in Tension Type Headache and Migraine
NCT03727672 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Salivary Inflammatory Markers (Interleukin -1β, Interleukin -6, C- Reactive Protein) in Tension Type Headache and Migraine
- Lead sponsor
- National and Kapodistrian University of Athens
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2016
- Completion date
- December 30, 2020
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
migraine, tension-type headache